pharmaphorum13 分钟
PBM reform dropped in Congress' funding package
The stripping of the legislation from the short-term funding package was described as a "missed opportunity" by the National ...
pharmaphorum1 小时
FDA clears Ionis drug as first therapy for rare disease FCS
Ionis Pharma's olezarsen has become the first FDA-approved drug therapy for adults with familial chylomicronaemia syndrome ...
pharmaphorum3 小时
Lilly grabs first-ever FDA nod for a sleep apnoea drug
Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related ...
pharmaphorum4 小时
Novo Nordisk sheds billions in value on obesity data
Novo Nordisk and Eli Lilly are currently a duopoly in the obesity market, which reached a value of $24 billion last year ...